Skip to main contentSkip to navigationSkip to search

Siegfried

Siegfried is a leading contract development and manufacturing organization (CDMO), delivering high-quality pharmaceutical ingredients and finished products to over 500 customers worldwide. The company operates a global network of production sites across Europe, North America, and Asia, offering fully integrated services spanning process development, optimization, registration, production, packaging, and logistics.

Founded

1873

Headquarters

Zofingen, Switzerland

Sector

Healthcare

Investment year

2022

Company description

Siegfried provides end-to-end capabilities in Drug Substances (APIs) and Drug Products (e.g., oral solids, sterile injectables, and ophthalmics), enabling seamless transitions from early-stage development to commercial manufacturing. Its global footprint ensures flexibility, scalability, and consistent quality across a wide range of therapeutic areas.

Built on Swiss precision, global reach, and deep scientific expertise, Siegfried is a trusted partner for complex pharmaceutical challenges. With more than 150 years of experience and a strong commitment to innovation, sustainability, and regulatory excellence, the company continues to shape the future of pharmaceutical manufacturing with quality, reliability, and purpose.

Siegfried